BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19889886)

  • 1. Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicity.
    Ulisse S; Arlot-Bonnemains Y; Baldini E; Morrone S; Carocci S; Di Luigi L; D'Armiento M
    J Endocrinol; 2010 Feb; 204(2):135-42. PubMed ID: 19889886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.
    Baldini E; Arlot-Bonnemains Y; Sorrenti S; Mian C; Pelizzo MR; De Antoni E; Palermo S; Morrone S; Barollo S; Nesca A; Moretti CG; D'Armiento M; Ulisse S
    BMC Cancer; 2011 Sep; 11():411. PubMed ID: 21943074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines.
    Arlot-Bonnemains Y; Baldini E; Martin B; Delcros JG; Toller M; Curcio F; Ambesi-Impiombato FS; D'Armiento M; Ulisse S
    Endocr Relat Cancer; 2008 Jun; 15(2):559-68. PubMed ID: 18430894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells.
    Xu DR; Huang S; Long ZJ; Chen JJ; Zou ZZ; Li J; Lin DJ; Liu Q
    J Transl Med; 2011 May; 9():74. PubMed ID: 21600017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells.
    Wang W; Stukenberg PT; Brautigan DL
    Mol Biol Cell; 2008 Nov; 19(11):4852-62. PubMed ID: 18716057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells.
    Pan C; Yan M; Yao J; Xu J; Long Z; Huang H; Liu Q
    Oral Oncol; 2008 Jul; 44(7):639-45. PubMed ID: 17996488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatio-temporal expression patterns of aurora kinases a, B, and C and cytoplasmic polyadenylation-element-binding protein in bovine oocytes during meiotic maturation.
    Uzbekova S; Arlot-Bonnemains Y; Dupont J; Dalbiès-Tran R; Papillier P; Pennetier S; Thélie A; Perreau C; Mermillod P; Prigent C; Uzbekov R
    Biol Reprod; 2008 Feb; 78(2):218-33. PubMed ID: 17687118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
    Fiskus W; Hembruff SL; Rao R; Sharma P; Balusu R; Venkannagari S; Smith JE; Peth K; Peiper SC; Bhalla KN
    Breast Cancer Res Treat; 2012 Sep; 135(2):433-44. PubMed ID: 22825030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
    Payton M; Bush TL; Chung G; Ziegler B; Eden P; McElroy P; Ross S; Cee VJ; Deak HL; Hodous BL; Nguyen HN; Olivieri PR; Romero K; Schenkel LB; Bak A; Stanton M; Dussault I; Patel VF; Geuns-Meyer S; Radinsky R; Kendall RL
    Cancer Res; 2010 Dec; 70(23):9846-54. PubMed ID: 20935223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
    Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aurora kinases: role in cell transformation and tumorigenesis.
    Katayama H; Brinkley WR; Sen S
    Cancer Metastasis Rev; 2003 Dec; 22(4):451-64. PubMed ID: 12884918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases.
    Crosio C; Fimia GM; Loury R; Kimura M; Okano Y; Zhou H; Sen S; Allis CD; Sassone-Corsi P
    Mol Cell Biol; 2002 Feb; 22(3):874-85. PubMed ID: 11784863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines.
    Chowdhury A; Chowdhury S; Tsai MY
    Leuk Lymphoma; 2012 Mar; 53(3):462-71. PubMed ID: 21879811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora kinase B modulates chromosome alignment in mouse oocytes.
    Shuda K; Schindler K; Ma J; Schultz RM; Donovan PJ
    Mol Reprod Dev; 2009 Nov; 76(11):1094-105. PubMed ID: 19565641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.
    Mahadevan D; Stejskal A; Cooke LS; Manziello A; Morales C; Persky DO; Fisher RI; Miller TP; Qi W
    Clin Cancer Res; 2012 Apr; 18(8):2210-9. PubMed ID: 22374334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrity of p53 associated pathways determines induction of apoptosis of tumor cells resistant to Aurora-A kinase inhibitors.
    Shionome Y; Yan L; Liu S; Saeki T; Ouchi T
    PLoS One; 2013; 8(1):e55457. PubMed ID: 23383195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mitotic phosphorylation of borealin.
    Kaur H; Stiff AC; Date DA; Taylor WR
    BMC Cell Biol; 2007 Jan; 8():5. PubMed ID: 17241471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
    Kaestner P; Stolz A; Bastians H
    Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel.
    Shimomura T; Hasako S; Nakatsuru Y; Mita T; Ichikawa K; Kodera T; Sakai T; Nambu T; Miyamoto M; Takahashi I; Miki S; Kawanishi N; Ohkubo M; Kotani H; Iwasawa Y
    Mol Cancer Ther; 2010 Jan; 9(1):157-66. PubMed ID: 20053775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.